Latest stories on CHRS
Coherus Oncology, Inc. (CHRS) files 8-K
SEC 8-K50 · neutralgeneral
Coherus Biosciences Announces 2026 Stockholder Meeting Results
TipRanks50 · neutralgeneral
Coherus Biosciences Signals Momentum in Earnings Call
TipRanks58 · neutralearnings